Drug Trial Radar · NCT00585975
Efficacy and Safety of Bromfenac Ophthalmic Solution
Last checked: Nov 20, 2026Latest source record: Feb 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
568
Actual
Start
Oct 2007
Primary completion
Jul 2008
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Jan 4, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a safety and efficacy study of bromfenac ophthalmic solution
Conditions
- Cataract Surgery
Interventions
bromfenac ophthalmic solutionDrug
sterile opthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Summed Ocular Inflammation Score (SOIS) of ZeroTime frame: Day 15
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ISTA Pharmaceuticals, Inc.
Irvine, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.